Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.

Access to cancer genomics and precision oncology remains profoundly unequal worldwide, limiting benefits for millions of patients and hindering research progress.

• Why it matters: Addressing these disparities is crucial to ensure equitable, effective, and sustainable cancer care and research, especially as precision oncology becomes central to treatment.
• What they did: The Commission analyzed the global landscape, identifying challenges and developing frameworks—including resource stratification, system readiness, workforce competency, and data sharing principles—to guide implementation.
• The result: Implementing these strategies can enhance health outcomes, promote equitable access, and enable health systems to integrate precision oncology responsibly, efficiently, and in line with patient and societal needs.